Entasis Therapeutics Holdings Inc. EBITDA 2018-2022 | ETTX
Entasis Therapeutics Holdings Inc. ebitda from 2018 to 2022. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Entasis Therapeutics Holdings Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2021 | $-52 |
| 2020 | $-54 |
| 2019 | $-47 |
| 2018 | $-38 |
| 2017 | $-31 |
| 2016 | $-19 |
| Entasis Therapeutics Holdings Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2022-03-31 | $-16 |
| 2021-12-31 | $-13 |
| 2021-09-30 | $-14 |
| 2021-06-30 | $-13 |
| 2021-03-31 | $-13 |
| 2020-12-31 | $-13 |
| 2020-09-30 | $-13 |
| 2020-06-30 | $-13 |
| 2020-03-31 | $-15 |
| 2019-12-31 | $-15 |
| 2019-09-30 | $-4 |
| 2019-06-30 | $-14 |
| 2019-03-31 | $-14 |
| 2018-12-31 | $-9 |
| 2018-09-30 | $-10 |
| 2018-06-30 | $-7 |
| 2018-03-31 | $-12 |
| 2017-09-30 | $-9 |
